Latest Posts
big data Biopharma Biopharmaceuticals biotech Biotech Billionaire Breaking In Biotech Data Google Nightingale
Google Mines Healthcare Data For Project ‘Nightingale’
Nobody can deny the fact that the healthcare industry is booming nowadays and has become a multi-billion industry. Due toContinue Reading
1000 Biopharma Biopharmaceuticals biotech Biotech Billionaire Biotech Hub Booklet Breaking In Biotech ebook How to Limited Time Only Pharma
New Ebook on Amazon, Learn How to Break Into the Biotech Industry
Ever wonder how to break into the biotech industry? We are happy to give out a free booklet that detailsContinue Reading
Artificial Intelligence biotech Breaking In Cancer CEO China Future Futuristic Insilico Insilico Medicine Interview Living Longer Pharma Uncategorized
Conversations with a CEO: Biotech Brothers Interviews Dr. Alex Zhavoronkov
As someone who writes about pharma and the biotech industry, I get invited to join the sidelines in hearing theContinue Reading
Uncategorized Pharma biotech healthcare Biotech Billionaire Career Life Science Science Biopharmaceuticals Biopharma Biotech Hub Breaking In Biotech science jobs science job
The Best Paying Jobs in STEM
Pursuing a science job can be amazing since it helps you establish a career and pursue amazing things in life.Continue Reading
Biopharma Biopharmaceuticals biotech Breaking In Biotech chemistry medicinal chemistry Medicine Pharma
What is Medicinal Chemistry?
Medicinal chemistry is one of the fields in very high demand at this particular time. It’s a discipline in betweenContinue Reading
acquisitions Astellas Astellas Pharma Biopharma Biopharmaceuticals biotech Biotech Billionaire Biotech Hub Buyout CAR T Life Science Pharma Research Science Uncategorized xyphos
Astellas Pharma Acquires CAR T Startup Xyphos for a Staggering $665 Million
Astellas Pharma will purchase Xyphos Biosciences for a staggering $665 million. A lot of money for CAR T technology thatContinue Reading
Academia Antibodies autoimmune disease biotech Cancer Drugs CNS Dr. Anna Fogdell Hahn Drug Development Drug Hunter Drugs Herpes HHV-6A HHV-6B Karolinska Institute MS Multiple Sclerosis Research Science Scientist virus
A Herpes Virus May Be the Cause of Multiple Sclerosis
Can a Herpes Variant be the clue to treating Multiple Sclerosis? With more than 8,700 MS patients and 7200 withoutContinue Reading
Beta Thalassemia Biopharma Biopharmaceuticals biotech Biotech Billionaire Cancer Drugs Clinical Trials Drug Development Drug Pricing Drugs George Tidmarsh Hemochromatosis La Jolla Pharmaceutical LJ401-BT01 Pharma Phase II Uncategorized
CEO Leaves on La Jolla Pharmaceutical’s Interim Data
An American biopharmaceutical company, La Jolla Pharmaceuticals (NASDAQ: LJPC), dedicated to the development of innovative novel therapies for patients sufferingContinue Reading
